As of 2026-09-12, the Relative Valuation of Biohaven Pharmaceutical Holding Company Ltd (BHVN) is (109.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.71 USD, the upside of Biohaven Pharmaceutical Holding Company Ltd based on Relative Valuation is -960.2%.
The range of the Relative Valuation is (100.80) - (112.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 25.9x - 30.3x | 29.7x |
| Forward P/E multiples | 24.6x - 28.8x | 26.4x |
| Fair Price | (100.80) - (112.25) | (109.33) |
| Upside | -893.0% - -983.2% | -960.2% |
| Date | P/E |
| 2026-09-04 | -4.03 |
| 2026-09-03 | -4.07 |
| 2026-09-02 | -4.03 |
| 2026-09-01 | -4.04 |
| 2026-08-31 | -3.92 |
| 2026-08-28 | -3.95 |
| 2026-08-27 | -4.14 |
| 2026-08-26 | -4.35 |
| 2026-08-25 | -3.69 |
| 2026-08-24 | -3.51 |
| 2026-08-21 | -3.55 |
| 2026-08-20 | -3.46 |
| 2026-08-19 | -3.63 |
| 2026-08-18 | -3.48 |
| 2026-08-17 | -3.71 |
| 2026-08-14 | -3.76 |
| 2026-08-13 | -3.81 |
| 2026-08-12 | -3.69 |
| 2026-08-11 | -3.72 |
| 2026-08-10 | -3.73 |
| 2026-08-07 | -3.76 |
| 2026-08-06 | -3.70 |
| 2026-08-05 | -3.50 |
| 2026-08-04 | -3.53 |
| 2026-08-03 | -3.43 |
| 2026-07-31 | -3.46 |
| 2026-07-30 | -3.55 |
| 2026-07-29 | -3.45 |
| 2026-07-28 | -3.53 |
| 2026-07-27 | -3.72 |
| 2026-07-24 | -3.67 |
| 2026-07-23 | -3.76 |
| 2026-07-22 | -3.78 |
| 2026-07-21 | -3.98 |
| 2026-07-20 | -3.81 |
| 2026-07-17 | -3.96 |
| 2026-07-16 | -3.64 |
| 2026-07-15 | -3.81 |
| 2026-07-14 | -3.83 |
| 2026-07-13 | -3.89 |
| 2026-07-10 | -3.99 |
| 2026-07-09 | -4.31 |
| 2026-07-08 | -4.27 |
| 2026-07-07 | -3.99 |
| 2026-07-06 | -4.12 |
| 2026-07-02 | -4.09 |
| 2026-07-01 | -4.04 |
| 2026-06-30 | -3.82 |
| 2026-06-29 | -3.84 |
| 2026-06-26 | -4.06 |